Ausschlusskriterien
Patients with a history of pure red cell aplasia or aplastic anemia
boolean
Patients who are experiencing unexplained loss or lack of effect to a recombinant erythropoietin product ongoing at the time of enrollment
boolean
Patients who have had prior recombinant erythropoietin treatment whose anemia had never responded (primary lack of efficacy)
boolean
Patients with a history of EPO antibodies prior to enrollment
boolean
Subjects who are currently receiving immunosuppressive medication (e.g., cyclosporine, tacrolimus, sirolimus, mycophenolic mofetil, azathioprine, or monoclonal antibodies) or corticosteroids at a dose corresponding to >15 mg/day prednisolone
boolean
Subjects whose first s.c. exposure to any erythropoietin product was >1 year prior to enrollment
boolean